NCT06074666 Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3
| NCT ID | NCT06074666 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Roswell Park Cancer Institute |
| Condition | Acute Lymphoblastic Leukemia, Pediatric |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-11-07 |
| Primary Completion | 2027-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2024-11-07 with a primary completion date of 2027-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The current study will assess the acceptability and feasibility of the CareMeds intervention with a larger sample (N = 100) across multiple sites in Buffalo, NY, and Atlanta, GA.
Eligibility Criteria
Inclusion Criteria: * Parent of a child who is diagnosed and being treated for any type of acute lymphoblastic leukemia (ALL) at a study site. * Parent has primary medication responsibility. * Pediatric patient aged 3-9 years * Child on therapy that includes home-based oral anti-cancer medication, such as 6-MP. * Parent has verbal English or Spanish fluency. * Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure Exclusion Criteria: * Parent is unwilling or unable to follow protocol requirements
Contact & Investigator
Elizabeth Bouchard, PhD
PRINCIPAL INVESTIGATOR
Roswell Park Comprehensive Cancer Center
Frequently Asked Questions
Who can join the NCT06074666 clinical trial?
This trial is open to participants of all sexes, aged 3 Years or older, up to 9 Years, studying Acute Lymphoblastic Leukemia, Pediatric. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06074666 currently recruiting?
Yes, NCT06074666 is actively recruiting participants. Contact the research team at Elizabeth.Bouchard@roswellpark.rog for enrollment information.
Where is the NCT06074666 trial being conducted?
This trial is being conducted at Buffalo, United States.
Who is sponsoring the NCT06074666 clinical trial?
NCT06074666 is sponsored by Roswell Park Cancer Institute. The principal investigator is Elizabeth Bouchard, PhD at Roswell Park Comprehensive Cancer Center. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.